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Abstract: Knowledge of factors regulating the turnover, repair, and degeneration of the intervertebral disc (IVD) is lack-
ing. Although type II collagen (CII) fragments accumulate in the degenerative IVD, little is known of how they affect the 
degenerative process. A better understanding of the cellular interactions with fragments of matrix molecules are a key fac-
tor in promoting therapies for degenerative disc diseases. In the present study, we have investigated the effect of the CII 
(245-270) peptide on the expression of matrix molecules, proteinases, and interleukin genes in cells of the IVD. Cells iso-
lated from the nucleus pulposus (NP) and annulus fibrosus (AF) of adult bovine tails were cultured up to 8 days in the ab-
sence (control) or presence of the CII (245-270) peptide. RT-PCR was used to analyze the expression of the different 
genes. Exposure of these cells to the CII (245-270) peptide led to a transient up-regulation of the aggrecan gene in AF 
cells while this up-regulation was maintained for a longer time in NP cells. The fragment also enhanced a transient up-
regulation of the type II collagen gene in AF cells but had no effect in NP cells. The peptide enhanced transiently the ex-
pression of matrix metalloproteinase (MMP)-1 and cathepsin K genes in both AF and NP cells whereas it increased 
MMP-13 expression only in NP cells. The peptide up-regulated tissue inhibitor of metalloproteinase (TIMP)-1, TIMP-2, 
and TIMP-3 gene expression on day 1 in AF cells but had very little effect on their expression in NP cells. Finally, the CII 
(245-270) peptide had no effect on IL-6 expression while IL-1 was not expressed in these cells. In conclusion, our re-
sults showed that the CII (245-270) peptide differentially alter the expression of genes in bovine AF and NP cells and 
suggest that degradation products of collagen may be involved in the regulation of IVD homeostasis. 
INTRODUCTION 
  Low back pain is the most prevalent of musculoskeletal 
clinical conditions. It affects nearly everyone at some point 
in time and about 4-33% of the population at any given point 
[1]. Although the etiology of low back pain is often unclear, 
it is believed that intervertebral disc (IVD) degeneration 
plays a major role as it increases steeply with age, so that 
60% of 70-year old discs are severely degenerated [2]. 
Though the majority of people affected will not require pro-
longed medical care or absence from work, about one third 
will require extensive care involving hospitalization [1]. 
Disorders of the lumbar spine that require surgical interven-
tion include herniated IVDs, spinal stenosis, degenerative 
spondylolisthesis, degenerative scoliosis, and degenerative 
disc diseases [3, 4]. While present management of IVD pa-
thology has been focused on symptoms associated with de-
generation, much less study has been devoted to the mecha-
nism of disc degeneration. 
  IVDs allow bending and twisting of the spine whilst re-
sisting compression from gravity and muscle action [5, 6]. 
They are composite structures of the peripheral annulus fi-
brosus (AF) enclosing the central nucleus pulposus (NP). 
Their development is complex, involving several different 
connective tissue types [6]. The ability of IVD tissue to resist 
compressive forces is largely due to their high content of the 
proteoglycan aggrecan. However, IVD proteoglycans   
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undergo changes in their metabolism and composition with 
ageing [7]. Thus, the reduction of aggrecan content observed 
with age within the disc may be the result of a decreased 
synthetic activity or an increased degradative capacity of the 
IVD cells. 
  Degeneration of the IVD results from excessive activity 
of tissue proteinases which degrade collagens of the extracel-
lular matrix (ECM) [8-14]. Matrix metallo-proteinases 
(MMPs) are a family of nine or more highly homologous 
Zn(++)-endopeptidases that collectively cleave most, if not 
all, of the constituents of the ECM [8-10]. They have been 
implicated in the excessive breakdown of ECM components 
during IVD degeneration [9,13]. Also, an imbalance in their 
production and activation, relative to their inhibition by tis-
sue inhibitors of metalloproteinases (TIMP) can cause IVD 
degeneration [8]. It has been suggested that MMP-1 has an 
important role in the degeneration of IVDs [10, 14]
 and that 
it is capable of degrading native fibrillar collagens in the 
ECM [15]. Furthermore, MMP-13 is a key enzyme in the 
development of osteoarthrtitis [16] and is associated with 
matrix mineralization [17]. 
  Fragments of type II collagen have been shown to cause 
inhibition of cell attachment to collagen, inhibition of colla-
gen synthesis, and induction of matrix degradation in carti-
lage [18]. These collagen fragments are elevated in degener-
ated discs, being significantly higher in both the AF and the 
NP than in articular cartilage [19]. Elevated levels of these 
fragments suggest that disc cells are responding to the al-
tered environment. Type II collagen fragments resulting 
from normal or enhanced proteolytic activity could be a 
mechanism that induces the cell to degrade the matrix fur-
ther. 2    The Open Orthopaedics Journal, 2008, Volume 2  Mwale et al. 
  We now propose to elucidate whether collagen fragments 
can also induce gene expression in the IVD. Specifically, we 
tested the ability of the type II collagen fragment, CII (245-
270), known to be critical in MHC class II antigen presenta-
tion of arthritis patients [20], to modulate the expression of 
proteinases and proteinase inhibitors, collagen, and aggregan 
in NP and AF cells of the IVD. This could be of great value 
in efforts to understand the regulation of collagen cleavage 
in disc degeneration. 
MATERIALS AND METHODOLOGY 
Source of Tissue 
  Bovine tails (2-3 years old) were obtained from Les Ab-
attoirs Billette (St-Louis-de- Gonzague, QC, Canada). All 
IVDs were classified as non-degenerated grade I according 
to the grading system of Thomson et al. [21]. 
Cell Isolation 
  Cells from 10 bovine tails (~15x10
6 cells from the AF per 
tail and ~5x10
6 cells from the NP per tail) were isolated im-
mediately after transportation from the abattoir. The proce-
dures were the same as described before [22]. Briefly, the 
IVDs were dissected from their adjacent vertebral bodies and 
placed in medium A, (DMEM-high glucose - 1 g/ml 
fungizone). Under aseptic conditions, the IVDs were sepa-
rated by dissection into regions corresponding to the AF and 
NP. The AF and NP were dissected into approximately 4-
mm thick fragments and were washed twice in medium A for 
15 min. 
  Cells were enzymatically isolated from the tissue using a 
sequential protease type XIV/collagenase protocol [22]. NP 
tissues were incubated overnight at 37°C with gentle agita-
tion (250 rpm) in DMEM high glucose supplemented with 
10% fetal bovine serum (FBS; HyClone, Logan, UT), 100 
U/ml penicillin, 100 μg/ml streptomycin, and 0.08% (w/v) 
collagenase (Sigma-Aldrich, Oakville, ON, Canada). AF 
tissues were digested first, for 1h at 37ºC under gentle agita-
tion (250 rpm) in DMEM high glucose supplemented with 
10% FBS, 100 U/ml penicillin, 100 μg/ml streptomycin, and 
0.4% (w/v) type XIV bacterial protease (Sigma-Aldrich) and 
then overnight with 0.06% collagenase. The resulting cell 
suspensions were passed through a 70-μm cell strainer (Bec-
ton Dickinson, Oakville, ON, Canada) and washed twice in 
DMEM high glucose supplemented with 10% FBS, 100 
U/ml penicillin, 100 μg/ml streptomycin, and 50 g/ml L-
ascorbic acid (Sigma-Aldrich). Cells were recovered by cen-
trifugation at 400  g for 5 min. Cells were counted in a 
hemacytometer  and the viability was determined using 
0.04% Trypan Blue. 
Cell Culture Conditions 
  Bovine AF and NP cells (1x10
5 cells in 10 ml medium) 
were cultured for 2 days in 100 mm dishes in DMEM-high 
glucose supplemented with 100 U/ml penicillin, 100 g/ml 
streptomycin, 2mM glutamine, 50 g/ml ascorbic acid (pre-
pared fresh), 1mg/ml bovine serum albumin (BSA), 5 g/ml 
insulin, 5 g/ml transferrin, 5 ng/ml sodium selenite. At the 
time of experiments, the CII (245-270) fragment (US Bio-
logical, Swampscott, MA), dissolved in culture media, and 
was added at final concentrations of 0.1 and 1 μg/ml.  
 
These concentrations were chosen from preliminary experi-
ments to reflect very low to high response in gene expres-
sion. The cells were maintained in a humidified incubator at 
37°C with 5% CO2 in air. The medium was changed every 
two days. 
Total RNA Isolation 
  Total RNA was extracted from bovine AF and NP cells 
by a modified method of Chomcynski and Sacchi [23] using 
TRIzol® reagent (Invitrogen, Burlington, ON, Canada). Af-
ter centrifugation for 15 min at 12,000  g at 4°C, the aque-
ous phase was precipitated in 1 volume isopropanol, incu-
bated for 60 min at room temperature, and centrifuged for 15 
min at 12,000  g at 4°C. The supernatant was discarded and 
the RNA pellet was air dried and then resuspended in 50 l 
DEPC-treated distilled water. Purity of the RNA was meas-
ured through the A260/A280 ratio. 
Reverse Transcriptase (RT) Reaction 
  The RT reaction was performed for 50 min at 42ºC using 
1.0 g total RNA. In 20 μl reaction volume, there is 50 mM 
Tris-HCl (pH 8.3), 75 mM KCL, 3 mM MgCl2, 10 mM 
DTT, 50 μM dNTP mixture, and 200 units of Superscript II 
RNAse H reverse transcriptase (Invitrogen). The inactivation 
reaction was achieved at 70ºC for 15 min. 
Polymerase Chain Reaction (PCR) 
  PCR was performed in a total volume of 25 μl contain-
ing: 10 mM Tris-HCl (pH 8.3), 1.5 mM MgCl2, 0.2 mM 
dNTP mixture, 0.8 μM of forward and reverse primers, 1μl 
of RT mixture, and 1.25 units of Taq DNA polymerase (Invi-
trogen). PCR procedure was according with the standard 
method [24, 25]. Thirty cycles were used for all genes. Every 
cycle consists of 1 min denaturation at 95°C, 1 min anneal-
ing at 55°C (COL2, AGG, MMP-1, TIMP-1, TIMP-3, 
CTSK, IL-6, and IL-1) or 50°C (MMP-13, TIMP-2, and 
18s rRNA), 1min polymerization at 72°C, followed by a 
final 10 min extension at 72°C. PCR products were separated 
on 2% agarose gel, visualized by ethidium bromide staining, 
and analyzed using the Bio-Rad VersaDoc equipped with a 
cooled charge coupled device (CCD) 12-bit camera (Bio-
Rad, Mississauga, Ontario, Canada). 18S rRNA was used as 
house keeping gene for gel loading and serves to normalize 
the results. To confirm the lack of genomic DNA contamina-
tion of RNA samples, PCR was also performed with RNA 
aliquots. The primers, specific for bovine genes, were ob-
tained from Invitrogen. The sequences of the primers used 
for PCR are described in Table 1. 
RESULTS 
Effect of the CII (245-270) Peptide on the Expression of 
Aggrecan and Type II Collagen 
  We first examined the expression of aggrecan because 
the discs resist compressive forces by their high content of 
the proteoglycans (predominantly aggrecan). Type II colla-
gen was studied because it is important for the integrity of 
the disc, as it forms the fibrous framework of the tissue. The 
expression of both aggrecan (AGG) and type II collagen 
(Col2) was constant throughout the time in culture in both 
AF and NP cells, except for AGG in the NP where a signifi-
cant increase was observed after 2 days (Fig. 1B,D). The CII  
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(245-270) peptide strongly up-regulated the expression of 
AGG on days 1 and 2 in the AF cells (3.7 times the control) 
while its expression returned to control levels thereafter (Fig. 
1A,C). Of special interest here was that the CII (245-270) 
peptide induced the expression of AGG only after 4 days in 
NP (2.8 times the control). This increase was maintained 
throughout the time in culture (Fig. 1B,D). This is in contrast 
to AF where the presence of the peptide induced AGG ex-
pression only at early time points. Results also showed that 
the CII (245-270) peptide enhanced the expression of Col2 
in a time-dependant manner with maximal stimulation 
reached after 2 days in culture (2.7 times the control) and a 
return to control level thereafter in AF cells (Fig. 1A,E). In 
NP cells, the CII (245-270) peptide had a slight up-
regulation of Col2 with a maximal stimulation reaching 1.8 
times the control after 4 days in culture (Fig. 1B,F). 
  At a lower concentration (0.1 g/ml), the CII (245-270) 
fragment had no effect on the expression of these genes (re-
sults not shown). 
Effect of the CII (245-270) Peptide on the Expression of 
Proteinases 
  Since MMP-1, MMP-13, and cathepsin K (CTSK) have 
been implicated in the breakdown of the disc ECM [8-14], we 
next tested the effect of the CII (245-270) peptide on these 
proteinases. The control MMP-1, MMP-13, and cathepsin K 
(CTSK) expression levels were constant throughout the time 
in culture in both AF and NP cells (Fig. 2). The expression of  
 
MMP-1 was enhanced by the CII (245-270) peptide in AF 
and NP cells in a time-dependent manner with maximal ef-
fect after 2 days for AF cells and after 4 days for NP cells 
(Fig. 2C,D). The stimulation decreased thereafter. MMP-13 
gene expression had a tendency to decrease in AF cells at 6 
and 8 days (Fig. 2E) while it tended to increase with time in 
NP cells (Fig. 2F). Except for day 1 in NP cells when MMP-
13 was increased (30 times the control), CII (245-270) pep-
tide had very little effect on the expression of MMP-13 (Fig. 
2E,F). Finally, addition of the CII (245-270) peptide led to a 
time-dependent increase of CTSK expression in AF cells 
with a maximal stimulation reached after 1 day in culture 
(2.9 times the control) and a decrease thereafter to reach con-
trol levels after 4 days in culture (Fig. 2G). In NP cells, the 
CII (245-270) peptide stimulated CTSK expression only 
after 1 day in culture (3.0 times the control) (Fig. 2H). 
  At a lower concentration (0.1 g/ml), the CII (245-270) 
fragment had no effect on the expression of these genes (re-
sults not shown). 
Effect of the CII (245-270) Peptide on the Expression of 
Tissue Inhibitor of Metalloproteinases (TIMPs) 
  Since MMPs are inhibited by specific endogenous tissue 
inhibitor of MMPs (TIMPs) [8], we next determined the effect 
of the CII (245-270) on TIMP-1, TIMP-2, and TIMP-3. The 
expression of control TIMP-1, TIMP-2, and TIMP-3 generally 
had a tendency to increase (not significantly) throughout the 
culture time (Fig. 3). In AF cells, the expression of TIMP-1  
 
Table 1.  Primer Sequences for the Study of Gene Expression 
 
Gene  Primer Sequence  Size of the  PCR Product 
AGG 
Forward (721-740): 5’-CAGAACATGCGC TCCAATGA-3’  
Reverse (1071-1090): 5’-CGTCATAGGTTTCGTTGGTG-3’ 
370 bp 
COL2 
Forward (949-970): 5’-GAACCCAGAAACACAATCC-3’  
Reverse (1075-1095): 5’-GTTCGGACTTTTCTCCCCTC-3’ 
147 bp 
MMP-1 
Forward (26-46): 5’-TCT GCT GCT GCT GCT ACT CTG-3’  
Reverse (400-419): 5’-TTT CTC AAT GGC TTG GTC CA-3’ 
394 bp 
MMP-13 
Forward (1237-1255): 5’-GATAAAGACTATCCGAGAC-3’  
Reverse (1365-1382): 5’-CGAACAATACGGTTACTC-3’ 
146 bp 
CTSK 
Forward (88-107): 5’-AAGAAGACCCACAGGAAGCA-3’ 
Reverse (537-558): 5’-AAGGCATTGGTCATGTAGCC-3’ 
471 bp 
TIMP-1 
Forward (377-394): 5’-GACAATTGTCGAATGGGC-3’ 
Reverse (716-740): 5’-CTGTTTCCACTCCCACCTTTTTTTC-3’ 
364 bp 
TIMP-2 
Forward (325-342): 5’-GAGTATCTCATTGCAGGG-3’  
Reverse (480-500): 5’-CAT GATCCCATGCTACATCTC-3’ 
176 bp 
TIMP-3 
Forward (181-200): 5’-GTCTACACCATCAAGGAGAT-3’  
Reverse (544-564): 5’-TTCTGCCGGATGCAAGCGTA-3’ 
384 bp 
IL-6 
Forward (1-19): 5’-ATGAACTCCCGCTTCACA-3’ 
Reverse (603-623): 5’-TTCATCCGAATAGCTCTCAGG-3’ 
623 bp 
IL-1 
Forward (126-146): 5’-ACTTCGTGAGGACCAGATGAA-3’ 
Reverse (746-765): 5’-ACTTGCCATGTGCACCAATT-3’ 
640 bp 
18S RNA 
Forward (153-176): 5’-CTA CTT GGA TAA CTG TGGTAA TTC-3’ 
Reverse (305-321): 5’-GAC TCT AGA TAA CCT CG-3’ 
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was stimulated by the CII (245-271) peptide after 1 day in 
culture and returned to control levels thereafter (Fig. 3C). The 
CII (245-270) peptide had no significant effect on TIMP-1 
gene expression in NP cells (Fig. 3D). Addition of the CII 
(245-270) peptide resulted in a significant increase of TIMP-2 
expression after 1 day in culture in AF cells (1.9 times the 
control) (Fig. 3E). The expression of TIMP-2 returned to con-
trol levels thereafter. In NP cells, the CII (245-270) peptide 
had no effect on the expression of TIMP-2 at the incubation 
times we studied (Fig. 3F). The addition of the CII (245-270) 
peptide to AF cells led to a significant increase of TIMP-3 
after 1 day in culture (2.3 times the control) and a 44% inhibi-
tion of its expression after 4 days in culture (Fig. 3G). In NP  
 
cells, the CII (245-270) peptide decreased the expression of 
TIMP-3 after 1 day (56% of control) and 8 days (63% of con-
trol) in culture whereas it had no effect on days 2, 4 and 6 
(Fig. 3H). 
  At a lower concentration (0.1 g/ml), the CII (245-270) 
fragment had no effect on the expression of these genes (re-
sults not shown). 
Effect of the CII (245-270) Peptide on the Expression of 
Interleukins (ILs) 
  Since cytokines are implicated in the ECM remodeling 
[26, 27] and IL-6 has been reported as an important cytokine  
 
 
 
Fig. (1). Effect of the CII (245-270) peptide on the gene expression of aggrecan (AGG) and type II collagen (Col2). AF and NP cells were 
incubated in the absence (Control (Ctl);--) or the presence of the CII (245-270) peptide (--). Agarose gels are representative of 3 experi-
ments while quantitative results are the mean ± SE of 3 experiments normalized to18S RNA content. 
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Fig. (2). Effect of the CII (245-270) peptide on the expression of proteinases. AF and NP cells were incubated in the absence (Control 
(Ctl);--) or the presence of the CII (245-270) peptide (--). Agarose gels are representative of 3 experiments while quantitative results are 
the mean ± SE of 3 experiments normalized to 18S RNA content. 
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Fig. (3). Effect of the CII (245-270) peptide on the expression of tissue inhibitor of metalloproteinases (TIMPs). AF and NP cells were incu-
bated in the absence (Control (Ctl);--) or the presence of the CII (245-270) peptide (--). Agarose gels are representative of 3 experiments 
while quantitative results are the mean ± SE of 3 experiments normalized to 18S RNA content. 
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in the IVD [28], we next examined the effect of the CII (245-
270) peptide on the expression of IL-6 and IL-1. The con-
trol IL-6 expression was not statistically different throughout 
the culture time in AF cells while a significant increase was 
observed in NP cells on day 2 (Fig. 4). A progressive de-
crease of this control level was observed thereafter. In AF 
cells, the CII (245-270) peptide had no significant effect on 
the expression of IL-6 (Fig. 4C). In NP cells, addition of the 
CII (245-270) peptide led to a time-dependent increase in IL-
6 expression with maximal stimulation reached after 4 days 
in culture (1.4 times the control) (Fig. 4D). The expression 
of IL-6 returned to control levels thereafter. At a lower con-
centration (0.1 g/ml), the CII (245-270) fragment had no 
effect on the expression of this genes (results not shown). 
Furthermore, IL-1 was neither expressed nor stimulated by 
the CII (245-270) peptide in these cells (results not shown). 
Effect of the CII (245-270) Peptide on MG-63 Osteoblast-
Like Cells 
  MG-63 osteoblast-like cells, cultured as previously de-
scribed [29], were used as control cells of non-IVD origin. 
The results show that the CII (245-270) peptide had no effect 
on these cells, both at 0.1 and 1 g/ml (results not shown). 
DISCUSSION 
  There is increasing evidence that once fragmentation of 
matrix molecules occurs around the disc, degradation prod-
ucts may further enhance matrix degradation [30, 31]. How-
ever, there has been no satisfactory explanation on the role of 
type II collagen fragments in disc degeneration, nor are there 
many details on how they affect collagenase expression. 
MMPs play an important role in the IVD but have received 
sparse attention in the literature [8]. The clinical significance 
is that knowledge of these feedback mechanisms, in which 
elevated concentrations of denatured collagens may play a 
role in the excessive resorption of matrix molecules observed 
in disc degeneration, may provide new therapeutic targets for 
regulation of disc destruction in degenerative disc disease. 
This field of application is of particular interest because con-
ventional treatments are disappointing in chronic low back 
pain. In this regard, it has been shown that type II collagen 
fragments inhibited cell attachment to collagen and collagen 
synthesis, and induced matrix degradation in cartilage [18]. 
Furthermore, it has been shown that the CII (245-270) frag-
ment can induce arthritis in an animal model [32]. This pep-
tide is the product of the cleavage of Col2 by cyanogen bro-
mide and may not exist in nature, even if it has arthritogenic 
potential [20]. However, similar peptides are present in the 
synovial fluid from which they enter the lymphatics and 
drain eventually into peripheral blood [33, 34]. It is also im-
portant to note that collagenase-cleaved collagens unwind 
and become susceptible to further degradation by other pro-
teinases in the extracellular space [35]. Nevertheless, the 
present results suggest that degradation products of collagen 
may be directly involved in the regulation of IVD homeosta-
sis. However, the CII (245-270) peptide had no significant 
effect on the proliferation of AF and NP cells (results not 
shown). 
  IVD and cartilage matrix degradation generates type II 
collagen fragments [18]. The objective of this study was to 
explore the possibility that these collagen fragments may be 
part of an endogenous metabolic feedback loop. The concept 
of endogenous metabolic feedback loop is supported by the 
finding that the CII (245-270) peptide can alter the expres-
sion of the key ECM genes like AGG and Col2. The stimula-
tion of MMP-1 in AF and NP cells, of MMP-13 in NP cells 
and of CTSK in AF cells also suggests that the CII (245-270) 
peptide stimulates a more generalized remodeling in disc 
cells. This is supported by the effect of the CII (245-270) 
 
Fig. (4). Effect of the CII (245-270) peptide on the expression of IL-6. AF and NP cells were incubated in the absence (Control (Ctl);--) or 
the presence of the CII (245-270) peptide (--). Agarose gels are representative of 3 experiments while quantitative results are the mean ± SE 
of 3 experiments normalized to 18S RNA content. 
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peptide on TIMP-1, TIMP-2, and TIMP-3 in AF and NP 
cells. 
  It is also worthy of note that the CII (245-270) fragment 
generally had a more pronounced effect on the expression of 
genes in AF cells than in NP cells, suggesting specificity in 
the effect of the CII (245-270) fragment. The specificity of 
the CII (245-270) peptide is also supported by the absence of 
effect of the CII (245-270) peptide on MG-63 osteoblast-like 
cells. Moreover, the very high effect on AGG in AF cells (30 
times the control) and the prolonged effect on MMP-13 in 
NP cells, which are different to that observed with the other 
genes, support a gene and tissue specificity of the CII (245-
270) peptide effects. In fact, proteolytic damage of collagens 
increases with age and becomes more extensive from the 
outer AF to the NP. The accumulation of such damaged col-
lagen would be eventually expected to weaken the mechani-
cal strength of the tissue, possibly adversely affecting the 
behavior of other spinal structures such as muscles and liga-
ments. Thus, the design of therapeutic targets for regulation 
of disc degeneration is important clinically because there is 
an association of IVD degeneration with back pain. How-
ever, it is difficult to be sure that AF and NP cell phenotypes 
are maintained throughout the time of culture since currently 
no universally accepted markers of these cells exist. It was 
for example demonstrated that there is significant reduction 
in Col2 and AGG mRNA in NP cell culture compared to 
fresh NP tissue, although the mRNA amounts remain rela-
tively constant after 2-4 passages [36]. Therefore, the long-
term effects of the CII (245-270) peptide on the expression 
of the different genes (return to control level or sustained 
expression) may also be due to phenotype changes, due to 
cell culture conditions and/or the presence of the CII (245-
270) peptide. This remains to be investigated. 
  It was suggested that cytokines are implicated in the 
ECM remodeling [26, 27]. In the present study, we showed 
that the CII (245-270) peptide had very weak effect on IL-6 
expression, suggesting that this cytokine is not implicated in 
the effect of collagen fragments. This suggests that IL-6 may 
be more important in response to pro-inflammatory stimulus 
such as lipopolysaccharide [37] or in presence of macro-
phages [38] than in the feedback effect of the CII (245-270) 
fragment on matrix turnover in IVD tissue. The effect of 
other collagen fragments on IL-6 expression remains to be 
investigated. Finally, the absence of IL-1 expression in 
both AF and NP cells is in agreement with previous studies 
showing the expression of this cytokine in only 39% of pa-
tients with herniated lumbar IVDs [39] and the fact that IL-6 
has been reported as the more significant cytokine in the 
IVD [28]. 
CONCLUSIONS 
  Taken together, our results suggest that collagen frag-
ments from the ECM are capable of interacting with cells 
from the IVD and may regulate many biological processes 
important to disc homeostasis, degeneration or repair. The 
expression of genes resulting from these interactions may 
vary in intensity and specificity, depending on the cell type. 
Thus, the present study highlights the importance of under-
standing cell matrix interactions at the molecular level. In-
deed, the effect of the CII (245-270) peptide on other ECM 
related genes (collagens, MMPs, TIMPs, etc.), the effect of 
other peptides produced by cyanogen bromide and generat-
ing T-cells response (CII (189-209) peptide) [20], and the 
existence of receptors for these peptides on AF and NP cells 
is yet to be established. 
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